Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study
1Department of Neurology, North Sichuan Road Branch of Shanghai First People’s Hospital, Shanghai 200081, China
2Neuroscience Research Australia, Randwick, NSW 2031, Australia
Abstract
none
Keywords
none
